Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Shared Decision Making for Schizophrenia

This study has been completed.
Sponsor:
Information provided by:
Technische Universität München
ClinicalTrials.gov Identifier:
NCT00220870
First received: September 15, 2005
Last updated: April 7, 2010
Last verified: April 2010

September 15, 2005
April 7, 2010
January 2003
Not Provided
Patients' compliance
Same as current
Complete list of historical versions of study NCT00220870 on ClinicalTrials.gov Archive Site
  • perceived involvement in medical decisions
  • rehospitalizations
  • QoL
Same as current
Not Provided
Not Provided
 
Shared Decision Making for Schizophrenia
Shared Decision Making in the Therapy of Schizophrenia

The impact of a decision aid for inpatients with schizophrenia on perceived involvement and compliance is studied in comparison with routine care.

to follow

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Schizophrenia
Behavioral: Decision aid
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
August 2005
Not Provided

Inclusion Criteria:

  • schizophrenia (ICD10)
  • age 18 - 65 years
  • inpatients

Exclusion Criteria:

  • mental retardation
  • no informed consent
Both
18 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00220870
217-43794-5/9, 217-43794-5/9
Not Provided
Not Provided
Technische Universität München
Not Provided
Study Chair: Werner Kissling, MD TU München, Psychiatric Department
Technische Universität München
April 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP